VANGUARD GROUP INC - Mar 31, 2025 Form SCHEDULE 13G/A Schedule Report for Crinetics Pharmaceuticals Inc (CRNX)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Crinetics Pharmaceuticals Inc Common Stock
Symbol: CRNX
Shares outstanding: 93.1M shares
Disclosed Ownership: 9.31M shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Date filed: 4/7/2025, 11:52 AM
Date of event: Mar 31, 2025
Previous filing: Jan 30, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	10%	9.31M	0	107K	Ashley Grim	Head of Global Fund Administration